{"id":209,"date":"2014-06-17T12:27:59","date_gmt":"2014-06-17T16:27:59","guid":{"rendered":"http:\/\/blogs.shu.edu\/cancer\/?p=209"},"modified":"2021-07-02T08:52:01","modified_gmt":"2021-07-02T12:52:01","slug":"autophagy-inhibitors-for-resistant-cancers","status":"publish","type":"post","link":"https:\/\/blogs.shu.edu\/cancer\/2014\/06\/17\/autophagy-inhibitors-for-resistant-cancers\/","title":{"rendered":"Autophagy inhibitors for resistant cancers"},"content":{"rendered":"<p>Autophagy is a process by which cells that are under stress and deprived of nutrients pause to recycle themselves in order to maintain viability. \u00a0Autophagosomes comprised of cellular organelles are formed, followed by Lysosomal destruction; the cell then uses the substrates for synthesis and reconstitution. \u00a0Cells in autophagy do not replicate&#8230;<!--more--><\/p>\n<p>Cancer cells frequently invoke autophagy programs as a respite to conserve energy and resources until conditions favorable for replication are restored. \u00a0Hence, autophagy is cytoprotective.<\/p>\n<p>Autophagy has also been observed in cancer cells as a mechanism of chemotherapy resistance. \u00a0This study by <a title=\"Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer\" href=\"http:\/\/m.clincancerres.aacrjournals.org\/content\/20\/12\/3159.full\" target=\"_blank\" rel=\"noopener\">Chittarajan et al.<\/a>, sought to evaluate autophagy inhibition in triple negative breast cancer models. \u00a0TNBC is characterized by lack of receptors for estrogen, progesterone, and HER-2\/neu. \u00a0Most patients with TNBC develop chemotherapy resistance.<\/p>\n<p>Hydroxychloroquine causes lysosomal acidification and inhibition of fusion of autophagosomes with lysosomes, which causes the accumulation of autophagosomes and rapid cell death. \u00a0(see <a href=\"http:\/\/blogs.shu.edu\/cancer\/files\/2014\/06\/Liu-et-al-hydroxychloroquine-ol_7_4_1057_PDF-1.pdf\">Liu et al &#8211; hydroxychloroquine ol_7_4_1057_PDF (1)<\/a>.) \u00a0The authors demonstrated a significant reduction in growth of epirubicin resistant TNBC with a combination of hydroxychloroquine and epirubicin &#8211;\u00a0<a href=\"http:\/\/blogs.shu.edu\/cancer\/files\/2014\/06\/Autophagy-Clin-Cancer-Res-2014-Chittaranjan-3159-73.pdf\">Autophagy Clin Cancer Res-2014-Chittaranjan-3159-73<\/a>.<\/p>\n<p>The results of this experiment suggest that autophagy inhibitors combined with chemotherapy in patients with chemo-resistant TNBC is a rational clinical strategy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Autophagy is a process by which cells that are under stress and deprived of nutrients pause to recycle themselves in order to maintain viability. \u00a0Autophagosomes comprised of cellular organelles are formed, followed by Lysosomal destruction; the cell then uses the substrates for synthesis and reconstitution. \u00a0Cells in autophagy do not replicate&#8230;<\/p>\n","protected":false},"author":2252,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3,37,31,1],"tags":[115,117,116],"class_list":["post-209","post","type-post","status-publish","format-standard","hentry","category-biology","category-resistance","category-traditional-chemotherapy","category-uncategorized","tag-autophagy","tag-hydroxyquinone","tag-triple-negative-breast-cancer"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/posts\/209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/users\/2252"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/comments?post=209"}],"version-history":[{"count":2,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/posts\/209\/revisions"}],"predecessor-version":[{"id":5025,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/posts\/209\/revisions\/5025"}],"wp:attachment":[{"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/media?parent=209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/categories?post=209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.shu.edu\/cancer\/wp-json\/wp\/v2\/tags?post=209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}